NLRC4 and liver dysplastic nodule: NLRC4‐driven IL‐1β production has also been shown to contribute to pathology in DN, where NLRC4‐deficient mice showed decreased blood glucose and albumin excretion, together with preserved renal histology and lower DN progression [19].